Literature DB >> 8410413

Postmenopausal hormone replacement: are two hormones better than one?

H Wood1, R Wang-Cheng, A B Nattinger.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8410413     DOI： 10.1007/bf02599627

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  99 in total

1.  Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.

Authors:  V T Miller; R A Muesing; J C LaRosa; D B Stoy; E A Phillips; R J Stillman
Journal:  Obstet Gynecol       Date:  1991-02       Impact factor: 7.661

2.  Biologic effects of transdermal estradiol.

Authors:  R J Chetkowski; D R Meldrum; K A Steingold; D Randle; J K Lu; P Eggena; J M Hershman; N K Alkjaersig; A P Fletcher; H L Judd
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

3.  Estrogen use and cardiovascular disease.

Authors:  B E Henderson; R K Ross; A Paganini-Hill; T M Mack
Journal:  Am J Obstet Gynecol       Date:  1986-06       Impact factor: 8.661

4.  The minimum effective dose of estrogen for prevention of postmenopausal bone loss.

Authors:  R Lindsay; D M Hart; D M Clark
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

5.  Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

Authors:  E Hirvonen; M Mälkönen; V Manninen
Journal:  N Engl J Med       Date:  1981-03-05       Impact factor: 91.245

6.  The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.

Authors:  S Haas; B Walsh; S Evans; M Krache; V Ravnikar; I Schiff
Journal:  Obstet Gynecol       Date:  1988-05       Impact factor: 7.661

Review 7.  The role and use of progestogens.

Authors:  M I Whitehead; T C Hillard; D Crook
Journal:  Obstet Gynecol       Date:  1990-04       Impact factor: 7.661

8.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

Authors:  I Persson; H O Adami; L Bergkvist; A Lindgren; B Pettersson; R Hoover; C Schairer
Journal:  BMJ       Date:  1989-01-21

9.  Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

Authors:  K Hunt; M Vessey; K McPherson; M Coleman
Journal:  Br J Obstet Gynaecol       Date:  1987-07

10.  Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient.

Authors:  L Weinstein; C Bewtra; J C Gallagher
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.